The University of Chicago Header Logo

Connection

Seenu Hariprasad to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Seenu Hariprasad has written about Cost-Benefit Analysis.
Seenu Hariprasad
Connection Strength
0.042
Cost-Benefit Analysis
  1. Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis. Value Health. 2022 10; 25(10):1705-1716.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.